PharmaLegacy Laboratories (Shanghai) Co., Ltdis a DMPK,Respiratory Disease Modelx2a38631nin one large multi-functional integrated modern enterprise,and devote the high-quality Rheumatoid arthritis Model and first-class service for the masses of customers.

   

PharmaLegacy Laboratories (Shanghai) Co., Ltd is specialized in Business services,Medical service,Medical insurance since established in 10 years ago.So far,our company has established its branch companies in major cities throughout the country.Formed in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China as the center, the radiation sales system and service network.Details:Drug Metabolism and Pharmacokinetics (DMPK) deals with the fate of a drug administered by various routes in the living organism (humans and laboratory animals). It involves improving understanding of DMPK properties of the drug in experimental animals and humans and predict exposure-effect relationship with respect to time. In the past, suboptimal characterization and understanding of DMPK properties of drugs led to a much higher attrition/failure rate of drugs in the clinic. PharmaLegacy can provide a complete complementary PK/ADME service. Our team of DMPK scientists are dedicated to both discovery and development. This coupled with state-of-the-art instrumentation and supported by an AAALAC accredited vivarium, assists our clients from lead candidate selection through development and ensures a high quality of DMPK studies with cost-efficiency and fast turnaround. DMPK deals with the effect of human body on the drug. PharmaLegacy offers the clients a broad spectrum of high quality services in the areas of in vitro ADME, in vivo pharmacokinetics and bioanalysis services, with cost-efficiency and fast turnaround. The test articles range from small molecules to large molecules, such as protein and antibody. The animal species involved are non-human primate, canine, mice, rat, rabbit, guinea pig and mini pig.

   Adhering to the Sincere service, the pursuit of perfection spirit of enterprise, PharmaLegacy bases on long-term development, technology as the core, market-oriented, and constantly open up new areas, undertaking to provide fast, high-quality service for the vast numbers of users. For further information about PharmaLegacyRespiratory Disease Model, please visit our official website: www.pharmalegacy.com.

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings